26.02.2005 01:27:00

Digirad Hosts Product Demonstration at the American College of Cardiol

Digirad Hosts Product Demonstration at the American College of Cardiology's 54th Annual Scientific Session Exposition


    Business Editors/Health/Medical Writers

    POWAY, Calif.--(BUSINESS WIRE)--Feb. 25, 2005--Digirad Corporation (Nasdaq:DRAD), a leader in providing solid-state imaging products and services to physician offices, hospitals and imaging centers, today announced that it will host a product demonstration and technology overview for investors, analysts and media on Monday, March 7, at the American College of Cardiology's (ACC) 54th Annual Scientific Session at the Orange County Convention Center in Orlando, Florida. The demonstration will take place at 1:00 p.m. Eastern Time, at Digirad's exhibit booths #4362 and #4363 in Hall D.
    David Sheehan, President and CEO; Todd Clyde, CFO; and Richard L. Conwell, SVP of Technology are among the members of Digirad's management who will host the event.
    A limited number of complimentary exhibition passes are available to interested members of the media, investment community and industry. Passes will allow access to the event exhibits on Monday, March 7, from 9:00 a.m. to 5:00 p.m. Eastern Time. To attend the product demonstration and to obtain complimentary exhibition passes, please contact Zachary Bryant of Lippert/Heilshorn & Associates at 310-691-7100 (for investors) or Diana Bowden of Digirad at 858-726-1600 (for industry and media) by Friday, March 4.
    The American College of Cardiology, a 31,000-member non-profit professional medical society and teaching institution, is dedicated to fostering optimal cardiovascular care and disease prevention through professional education, promotion of research, leadership in the development of standards and guidelines, and the formulation of health care policy. The ACC Annual Scientific Session boasts over 27,000 attendees a year and offers a unique combination of cutting-edge science and practical clinical applications.

    About Digirad

    Digirad Corporation develops, manufactures and markets solid-state, digital gamma cameras to hospitals, imaging centers and physician offices. Digirad offers a comprehensive line of solid-state nuclear gamma cameras that produce a high-quality image for use in the detection of many medical conditions including cardiovascular disease. Digirad believes that its imaging systems produce a high-quality image; due to their lightweight and compact design, the systems fit easily into small office spaces.
    Through its wholly owned subsidiaries, Digirad Imaging Solutions and Digirad Imaging Systems, Digirad also offers a comprehensive and mobile imaging leasing and services program for physicians who wish to perform nuclear cardiology procedures in their offices but do not have the patient volume, capital or resources to justify purchasing a gamma camera. Digirad Corporation and subsidiaries are headquartered in Poway, California. For more information, please visit www.digirad.com. Digirad(R) and Digirad Imaging Solutions(R) are registered trademarks of Digirad Corporation. Cardius(TM) and DigiTech(SM) are trade and service marks of Digirad Corporation.

    DRADG

--30--WAM/la*

CONTACT: Digirad Corporation Diana Bowden, 858-726-1600 dbowden@digirad.com or Lippert/Heilshorn & Associates Ina McGuinness or Bruce Voss, 310-691-7100 imcguinness@lhai.com

KEYWORD: CALIFORNIA FLORIDA INDUSTRY KEYWORD: MEDICAL DEVICES MEDICAL TRADESHOW SOURCE: Digirad Corporation

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Digirad Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Digirad Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 478,88 -0,06%